Evidence map›Paper›PMID 25886853›Full record

ReviewCritical care (London, England)2015

Angiotensin II in septic shock.

Thiago D Corrêa, Jukka Takala, Stephan M Jakob

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06539234 (Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II in Relation to Hemodynamic Response to Treatment With Angiotensin II.), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06539234 recruitingnot on this mapstarted 2024, after this paper: background citation

Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II in Relation to Hemodynamic Response to Treatment With Angiotensin II.

TypeobservationalSponsorUniversity Medical Centre MariborRan2024 to 2026Enrolled80ConditionsShock, Vasoplegic Syndrome
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 99 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Angiotensin II-Real-Life Use and Literature Review.Medicina (Kaunas, Lithuania) · 2024
    Review
  14. Article
  15. Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  16. Review
  17. Drugs in treating paediatric acute kidney injury.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  18. Review
  19. Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis.Journal of cardiothoracic and vascular anesthesia · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thiago D CorrêaHospital Israelita Albert Einstein, Intensive Care Unit, São Paulo, Brazil. thiagodct@gmail.com.
Jukka TakalaDepartment of Intensive Care Medicine, Bern University Hospital, Inselspital, Bern, Switzerland. jukka.takala@insel.ch.
Stephan M JakobDepartment of Intensive Care Medicine, Bern University Hospital, Inselspital, Bern, Switzerland. stephan.jakob@insel.ch.
Bern University of Applied Sciences · CHHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.

Indexed as

Angiotensin IICritical CareHumansRenin-Angiotensin SystemShock, SepticVasoconstrictor AgentsAngiotensin IIVasoconstrictor Agents

Identifiers

PMID25886853
PMCPMC4360936
OpenAlexW2098703177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.